BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9721849)

  • 1. A glial-specific, repressible, adenovirus vector for brain tumor gene therapy.
    Chen J; Bezdek T; Chang J; Kherzai AW; Willingham T; Azzara M; Nisen PD
    Cancer Res; 1998 Aug; 58(16):3504-7. PubMed ID: 9721849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective astrocytic transgene expression in vitro and in vivo from the GFAP promoter in a HSV RL1 null mutant vector--potential glioblastoma targeting.
    McKie EA; Graham DI; Brown SM
    Gene Ther; 1998 Apr; 5(4):440-50. PubMed ID: 9614567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
    Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
    Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glioma/glioblastoma-specific adenoviral gene expression using the nestin gene regulator.
    Kurihara H; Zama A; Tamura M; Takeda J; Sasaki T; Takeuchi T
    Gene Ther; 2000 Apr; 7(8):686-93. PubMed ID: 10800092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate-specific antigen promoter/enhancer driven gene therapy for prostate cancer: construction and testing of a tissue-specific adenovirus vector.
    Latham JP; Searle PF; Mautner V; James ND
    Cancer Res; 2000 Jan; 60(2):334-41. PubMed ID: 10667585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased glia-specific transgene expression with glial fibrillary acidic protein promoters containing multiple enhancer elements.
    de Leeuw B; Su M; ter Horst M; Iwata S; Rodijk M; Hoeben RC; Messing A; Smitt PS; Brenner M
    J Neurosci Res; 2006 Apr; 83(5):744-53. PubMed ID: 16496373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional targeting of recombinant adenoviruses to human and murine melanoma cells.
    Siders WM; Halloran PJ; Fenton RG
    Cancer Res; 1996 Dec; 56(24):5638-46. PubMed ID: 8971169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting malignant gliomas with a glial fibrillary acidic protein (GFAP)-selective oncolytic adenovirus.
    Horst Mt; Brouwer E; Verwijnen S; Rodijk M; de Jong M; Hoeben R; de Leeuw B; Smitt PS
    J Gene Med; 2007 Dec; 9(12):1071-9. PubMed ID: 17902184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus-mediated expression of HSV1-TK or Fas ligand induces cell death in primary human glioma-derived cell cultures that are resistant to the chemotherapeutic agent CCNU.
    Maleniak TC; Darling JL; Lowenstein PR; Castro MG
    Cancer Gene Ther; 2001 Aug; 8(8):589-98. PubMed ID: 11571537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of glioma cells in vitro and in vivo using a recombinant adenoviral vector containing an astrocyte-specific promoter.
    Vandier D; Rixe O; Besnard F; Kim M; Rikiyama T; Goldsmith M; Brenner M; Gouyette A; Cowan KH
    Cancer Gene Ther; 2000 Aug; 7(8):1120-6. PubMed ID: 10975672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene-viral vectors: a promising way to target tumor cells and express anticancer genes simultaneously.
    Qian Q; Sham J; Che X; Xu J; Xue H; Cui Z; Zhu B; Wu M
    Chin Med J (Engl); 2002 Aug; 115(8):1213-7. PubMed ID: 12215295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapy for malignant glioma using Sindbis vectors expressing a fusogenic membrane glycoprotein.
    Zhang J; Frolov I; Russell SJ
    J Gene Med; 2004 Oct; 6(10):1082-91. PubMed ID: 15368589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant baculovirus containing the diphtheria toxin A gene for malignant glioma therapy.
    Wang CY; Li F; Yang Y; Guo HY; Wu CX; Wang S
    Cancer Res; 2006 Jun; 66(11):5798-806. PubMed ID: 16740719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene delivery to glioma cells in rat brain by grafting of a retrovirus packaging cell line.
    Short MP; Choi BC; Lee JK; Malick A; Breakefield XO; Martuza RL
    J Neurosci Res; 1990 Nov; 27(3):427-39. PubMed ID: 2129047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modifications of the fiber in adenovirus vectors increase tropism for malignant glioma models.
    Staba MJ; Wickham TJ; Kovesdi I; Hallahan DE
    Cancer Gene Ther; 2000 Jan; 7(1):13-9. PubMed ID: 10678351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced apoptosis following treatment with TRA-8 anti-human DR5 monoclonal antibody and overexpression of exogenous Bax in human glioma cells.
    Kaliberov S; Stackhouse MA; Kaliberova L; Zhou T; Buchsbaum DJ
    Gene Ther; 2004 Apr; 11(8):658-67. PubMed ID: 14973547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-type-specific and regulatable transgenesis in the adult brain: adenovirus-encoded combined transcriptional targeting and inducible transgene expression.
    Smith-Arica JR; Morelli AE; Larregina AT; Smith J; Lowenstein PR; Castro MG
    Mol Ther; 2000 Dec; 2(6):579-87. PubMed ID: 11124058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The human SCGB2A2 (mammaglobin-1) promoter/enhancer in a helper-dependent adenovirus vector directs high levels of transgene expression in mammary carcinoma cells but not in normal nonmammary cells.
    Shi CX; Long MA; Liu L; Graham FL; Gauldie J; Hitt MM
    Mol Ther; 2004 Oct; 10(4):758-67. PubMed ID: 15451460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetracycline-inducible transgene expression mediated by a single AAV vector.
    Chtarto A; Bender HU; Hanemann CO; Kemp T; Lehtonen E; Levivier M; Brotchi J; Velu T; Tenenbaum L
    Gene Ther; 2003 Jan; 10(1):84-94. PubMed ID: 12525840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A complex adenovirus vector that delivers FASL-GFP with combined prostate-specific and tetracycline-regulated expression.
    Rubinchik S; Wang D; Yu H; Fan F; Luo M; Norris JS; Dong JY
    Mol Ther; 2001 Nov; 4(5):416-26. PubMed ID: 11708878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.